Cerebrovascular Accident Clinical Trial
Verified date | February 2011 |
Source | University College of Antwerp |
Contact | n/a |
Is FDA regulated | No |
Health authority | Belgium: Institutional Review Board |
Study type | Observational |
Background:Accelerometry has only recently been introduced in clinical stroke research.
However, whether accelerometry is a valid and reliable tool in stroke needs to be
established. From literature becomes clear that existing accelerometers show shortages at
patients with stroke because of the specific deficits that these patients have.
Purpose: The aim of this study is to investigate the validity and test-retest reliability of
the SenseWear Pro armband as an objective measurement of physical activity in chronic stroke
patients.
Patients and Methods Subjects: Fifteen patients and fifteen healthy subjects will be
included in the study following written informed consent. The following demographic and
clinical data were recorded: age, gender, height, length, medication use, self-reported
handedness, Edinburgh Handedness Inventory, Rivermead Gross Function, Functional Ambulation
Categories, medical and surgical history.
Methods: During one test session the subjects had to carry out an amount of activities
according to a standardised protocol existing of lying down, sitting, standing, walking,
step exercise and cycling. These activities are presenting activities of daily living.
Measures:Subjects wear on both arms a SenseWear Pro Armband. De data from these measuring
devices will be compared with the data retrieved from 2 Yamax pedometers and the
ergospirometry device. The outcome measures are: counts, heartbeat, oxygen used, energy
expenditure, METabolic equivalent, time lying down.
Status | Completed |
Enrollment | 30 |
Est. completion date | September 2009 |
Est. primary completion date | September 2009 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Both |
Age group | 18 Years to 80 Years |
Eligibility |
Inclusion criteria: - an ischemic or hemorrhagic stroke - stroke onset less than 3 months - score 3 or more Functional Ambulation Categories - age < 80 years - ability to cycle independently - written authorisation on the informed consent Exclusion criteria: - serious other diseases which might have an influence on carrying out the standardised activities - cannot understand and carry out simple instructions |
Observational Model: Case Control, Time Perspective: Cross-Sectional
Country | Name | City | State |
---|---|---|---|
Belgium | University Hospital of Antwerp | Edegem | Antwerp |
Lead Sponsor | Collaborator |
---|---|
University College of Antwerp | Universiteit Antwerpen |
Belgium,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Total energy expenditure (kcal)during selected physical activities | measurement at 1 time point | No | |
Secondary | Number of steps | measurement at 1 time point | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05477238 -
Oxygen Consumption in Post-stroke Patients During Various Walking Activities Compared to Healthy Controls
|
N/A | |
Completed |
NCT00046293 -
ReoPro and Retavase to Treat Acute Stroke
|
Phase 2 | |
Completed |
NCT04584645 -
A Digital Flu Intervention for People With Cardiovascular Conditions
|
N/A | |
Completed |
NCT01116544 -
Treatment of Chronic Stroke With AMES + EMG Biofeedback
|
N/A | |
Withdrawn |
NCT04991038 -
Clinical Investigation to Compare Safety and Efficacy of DAISE and Stent Retrievers for Thrombectomy In Acute Ischemic Stroke Patients
|
N/A | |
Active, not recruiting |
NCT02563886 -
Electrically Assisted Movement Therapy
|
N/A | |
Recruiting |
NCT02446730 -
Efficacy and Safety of BiomatrixTM Stent and 5mg-Maintenance Dose of Prasugrel in Patients With Acute Coronary Syndrome
|
Phase 4 | |
Completed |
NCT02141932 -
Pocket-size Cardiovascular Ultrasound in Stroke
|
N/A | |
Completed |
NCT01915368 -
Determining Optimal Post-Stroke Exercise (DOSE)
|
N/A | |
Recruiting |
NCT01769326 -
Influence of Timing on Motor Learning
|
N/A | |
Recruiting |
NCT02557737 -
Botulinim Toxin Type A Injections by Different Guidance in Stroke Patients With Spasticity on Upper Extremities
|
Phase 3 | |
Terminated |
NCT01705353 -
The Role of HMGB-1 in Chronic Stroke
|
N/A | |
Completed |
NCT01423201 -
Transient Ischemic Attack (TIA) Triage and Evaluation of Stroke Risk
|
||
Completed |
NCT01182818 -
Fabry and Stroke Epidemiological Protocol (FASEP): Risk Factors In Ischemic Stroke Patients With Fabry Disease
|
N/A | |
Completed |
NCT01656876 -
The Effects of Mirror Therapy on Upper Extremity in Stroke Patients
|
N/A | |
Completed |
NCT00542256 -
tDCS and Physical Therapy in Stroke
|
N/A | |
Withdrawn |
NCT00573092 -
Analyzing Gene Regions That May Interact With the Effectiveness of High Blood Pressure Drugs
|
N/A | |
Completed |
NCT00377689 -
Evaluation of an Intervention Program Targeted at Improving Balance and Functional Skills After Stroke
|
Phase 2 | |
Recruiting |
NCT00166751 -
Sonographic Assessment of Laryngeal Elevation
|
N/A | |
Completed |
NCT00149435 -
Cardiovascular Health Study (CHS) Events Follow-up Study
|